Wenxia Xu

2.5k total citations · 1 hit paper
74 papers, 1.8k citations indexed

About

Wenxia Xu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Wenxia Xu has authored 74 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Molecular Biology, 25 papers in Cancer Research and 14 papers in Oncology. Recurrent topics in Wenxia Xu's work include Epigenetics and DNA Methylation (20 papers), Cancer, Hypoxia, and Metabolism (17 papers) and RNA modifications and cancer (12 papers). Wenxia Xu is often cited by papers focused on Epigenetics and DNA Methylation (20 papers), Cancer, Hypoxia, and Metabolism (17 papers) and RNA modifications and cancer (12 papers). Wenxia Xu collaborates with scholars based in China, Hong Kong and United States. Wenxia Xu's co-authors include Xian Wang, Hongchuan Jin, Lifeng Feng, Jianwei Zhou, Liyuan Zhu, Xiaoya Zhao, Jianfei Fu, Vivian Y. Shin, Yiran Zhu and Dongjun Dai and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Chemical Engineering Journal.

In The Last Decade

Wenxia Xu

70 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Exosomal circLPAR1 functions in colorectal cancer diagnosis and tumorigenesis through suppressing BRD4 via METTL3–eIF3h interaction

2022 158 citations Rui Zheng, Ke Zhang et al. Molecular Cancer profile →

Peers

Wenxia Xu

MB

CR

ONCOL

EPIDE

PRM

Amir Reza Aref United States

Shiyan Wang China

Jun Mao China

Yue Fan China

Chaoqun Wang China

Katarzyna Augoff Poland

Xingwu Wang China

Yan Xiang China

Frances L. Byrne Australia

Amir Reza Aref United States

Wenxia Xu

1.4k ×1.0

MB

914 ×1.1

CR

309 ×0.9

ONCOL

130 ×0.8

EPIDE

191 ×1.4

PRM

Citations per year, relative to Wenxia Xu Wenxia Xu (= 1×) peers Amir Reza Aref

Countries citing papers authored by Wenxia Xu

Since Specialization

Citations

This map shows the geographic impact of Wenxia Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenxia Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenxia Xu more than expected).

Fields of papers citing papers by Wenxia Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenxia Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenxia Xu. The network helps show where Wenxia Xu may publish in the future.

Co-authorship network of co-authors of Wenxia Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Wenxia Xu. A scholar is included among the top collaborators of Wenxia Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenxia Xu. Wenxia Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

He, Pan, et al.. (2025). Nanotechnology applications in geothermal energy systems: Advances, challenges and opportunities. ADVANCES IN GEO-ENERGY RESEARCH. 15(2). 172–180. 4 indexed citations

2.

Zhang, Xiaohan, Jie Huang, Na Zhou, et al.. (2025). Curcumin-alendronate carbon dots: A dual-logic strategy for precision treatment of periodontitis. Materials Today Bio. 33. 102073–102073.

3.

Zhan, Yuanbo, Tianyi Liu, Xuejing Song, et al.. (2024). Using formalin fixed paraffin embedded tissue to characterize the microbiota in p16-positive and p16-negative tongue squamous cell carcinoma: a pilot study. BMC Oral Health. 24(1). 283–283. 2 indexed citations

4.

Chen, Lin, Zhihui Dai, Bin Hu, et al.. (2024). Integrative metabolome and transcriptome analyses provide insights into PHGDH in colon cancer organoids. Bioscience Reports. 45(1). 1–12. 3 indexed citations

5.

Dai, Zhihui, Lin Chen, Xiaoya Zhao, et al.. (2023). Multi-omics Analysis of the Role of PHGDH in Colon Cancer. Technology in Cancer Research & Treatment. 22. 2213887882–2213887882. 7 indexed citations

6.

Wang, Jianqun, Wenxia Xu, Wenxuan Zhang, et al.. (2023). UV cross-linked injectable non-swelling dihydrocaffeic acid grafted chitosan hydrogel for promoting wound healing. Carbohydrate Polymers. 314. 120926–120926. 29 indexed citations

7.

Zheng, Rui, Ke Zhang, Fang Gao, et al.. (2022). Exosomal circLPAR1 functions in colorectal cancer diagnosis and tumorigenesis through suppressing BRD4 via METTL3–eIF3h interaction. Molecular Cancer. 21(1). 49–49. 158 indexed citations breakdown →

8.

Fu, Liang, et al.. (2022). Metabolomics studies on cachexia in patients with cancer: a scoping review protocol. BMJ Open. 12(4). e052125–e052125. 1 indexed citations

9.

Fu, Liang, et al.. (2022). Financial toxicity in patients with lung cancer: a scoping review protocol. BMJ Open. 12(5). e057801–e057801. 4 indexed citations

10.

Hu, Bin, et al.. (2022). STUB1-SMYD2 Axis Regulates Drug Resistance in Glioma cells. Journal of Molecular Neuroscience. 72(9). 2030–2044. 8 indexed citations

11.

Xu, Wenxia, et al.. (2021). Role of Ubiquitin-Specific Peptidase 47 in Cancers and Other Diseases. Frontiers in Cell and Developmental Biology. 9. 726632–726632. 13 indexed citations

12.

Wang, Jian‐Jun, et al.. (2021). Role of HOXC10 in Cancer. Frontiers in Oncology. 11. 684021–684021. 11 indexed citations

13.

Du, Weibin, et al.. (2020). An mRNA sequencing analysis of the healing-promoting role of electroacupuncture a in rat skin wound model. Annals of Palliative Medicine. 9(4). 1462–1475. 6 indexed citations

14.

Zhao, Xiaoya, et al.. (2020). <p>Inhibition of Serine Metabolism Promotes Resistance to Cisplatin in Gastric Cancer</p>. OncoTargets and Therapy. Volume 13. 4833–4842. 20 indexed citations

15.

Li, Jiaqiu, Ping Song, Tingting Jiang, et al.. (2018). Heat Shock Factor 1 Epigenetically Stimulates Glutaminase-1-Dependent mTOR Activation to Promote Colorectal Carcinogenesis. Molecular Therapy. 26(7). 1828–1839. 72 indexed citations

16.

Xu, Wenxia, Wei Qi, Mengjiao Han, et al.. (2018). CCL2-SQSTM1 positive feedback loop suppresses autophagy to promote chemoresistance in gastric cancer. International Journal of Biological Sciences. 14(9). 1054–1066. 45 indexed citations

17.

Yang, Ye, Yanfei Fang, Wenxia Xu, et al.. (2016). 3,3′-Diindolylmethane induces anti-human gastric cancer cells by the miR-30e-ATG5 modulating autophagy. Biochemical Pharmacology. 115. 77–84. 63 indexed citations

18.

Zhang, Yajie, et al.. (2016). MiR-99a and MiR-491 Regulate Cisplatin Resistance in Human Gastric Cancer Cells by Targeting CAPNS1. International Journal of Biological Sciences. 12(12). 1437–1447. 60 indexed citations

19.

Xu, Wenxia, Yajie Zhang, Qi Chen, et al.. (2015). TXNL1 Induces Apoptosis in Cisplatin Resistant Human Gastric Cancer Cell Lines. Current Cancer Drug Targets. 14(9). 850–859. 18 indexed citations

20.

Shi, Lei, et al.. (2010). Recombinant adenovirus IL-24-Bax promotes apoptosis of hepatocellular carcinoma cells in vitro and in vivo. Cancer Gene Therapy. 17(11). 771–779. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact